Business

Thailand launches high-volume coronavirus vaccination drive due to surge in cases

Thailand will launch the Covid-19 vaccination program on Monday, primarily Oxford / Astra produced by Siam Biosciences, a company owned by King Maha Vatilla Roncon, who has never produced a vaccine. Focuses on Zeneca Jab.

This development is significant for both the Prayut Chan-Ocha administration, which faces growing anger from the general public and businesses over the delay in vaccine delivery, and AstraZeneca, which chose Thailand as its production hub in Southeast Asia. It’s a bet.

Siam Bioscience produces 200 million coronavirus jabs, including for export.

Thailand Rapid increase in infectious diseases Approximately 2,000 to 4,000 new cases are reported per day, the highest since the pandemic began.

Like a local peer Vietnam And TaiwanThe Kingdom has eliminated Covid-19 infections reported in 2020. The surge in cases has been attributed to the more contagious variants of the coronavirus that have spread rapidly through markets, prisons and worker camps. I have.

However, Siam Bioscience showed signs of production delays.Philippines Said Last week, the first batch of 17 million batches expected from Thailand was delayed and reduced in size.

Separately, the Thai Rural Medical Association claims that the government had imported 500,000 doses of AstraZeneca vaccine from South Korea to make up for production shortages. Some Thais were vaccinated in June. Reported that he was told that he could make a reservation.

Thai government last week Received delivery 1.8 million jabs from AstraZeneca, the first of the 6 million vaccines to arrive this month. A government spokesman refused to answer the Financial Times’ question about whether to use jabs imported from South Korea with locally made jabs, although the rollout claims to be on schedule. Siam Bioscience declined to comment, and AstraZeneca’s Thai office did not respond to requests for comment.

A frank online publication, Thai Enquirer called Siam Bioscience an “international embarrassment” last week.

Serum Institute of India So it’s a mistake to expect everything with the first producer, Siam Bioscience, to go as smoothly as silk. “” But AstraZeneca can do a lot by acting more proactively. Probably. ”

Due to the surge in infections earlier this year, the Thai government has been accused of relying too much on a single vaccine produced by the first vaccine manufacturer. More recently, it has been working to increase the supply of jabs from alternative suppliers such as Chinese pharmaceutical companies Sinovac, BioNTech / Pfizer, and US pharmaceutical companies Johnson & Johnson.

Thai freedom to criticize Siam bioscience Owned by the King of Billionaires, And statements that are considered insulting to the royal family are criminal.

Thanathorn Juan Kit, Thailand’s most famous opposition, was charged with blasphemy and “computer crime” in January after commenting online on what he called the “royal vaccine.”

The power and wealth of the 69-year-old King of Thailand received unusual criticism from last year’s youth-led participants. Democracy protest..

Additional report by Ryn Jirenuwat in Bangkok

Follow us on Twitter: @JohnReedwrites

Latest coronavirus news

Follow FT’s live coverage and analysis of the global pandemic and rapidly evolving economic crisis Here..



Thailand launches high-volume coronavirus vaccination drive due to surge in cases

Source link Thailand launches high-volume coronavirus vaccination drive due to surge in cases

Back to top button